Paradoxical Effects of Rapamycin on Experimental House Dust Mite-Induced Asthma
Open Access
- 25 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5) , e33984
Abstract
The mammalian target of rapamycin (mTOR) modulates immune responses and cellular proliferation. The objective of this study was to assess whether inhibition of mTOR with rapamycin modifies disease severity in two experimental murine models of house dust mite (HDM)-induced asthma. In an induction model, rapamycin was administered to BALB/c mice coincident with nasal HDM challenges for 3 weeks. In a treatment model, nasal HDM challenges were performed for 6 weeks and rapamycin treatment was administered during weeks 4 through 6. In the induction model, rapamycin significantly attenuated airway inflammation, airway hyperreactivity (AHR) and goblet cell hyperplasia. In contrast, treatment of established HDM-induced asthma with rapamycin exacerbated AHR and airway inflammation, whereas goblet cell hyperplasia was not modified. Phosphorylation of the S6 ribosomal protein, which is downstream of mTORC1, was increased after 3 weeks, but not 6 weeks of HDM-challenge. Rapamycin reduced S6 phosphorylation in HDM-challenged mice in both the induction and treatment models. Thus, the paradoxical effects of rapamycin on asthma severity paralleled the activation of mTOR signaling. Lastly, mediastinal lymph node re-stimulation experiments showed that treatment of rapamycin-naive T cells with ex vivo rapamycin decreased antigen-specific Th2 cytokine production, whereas prior exposure to in vivo rapamycin rendered T cells refractory to the suppressive effects of ex vivo rapamycin. We conclude that rapamycin had paradoxical effects on the pathogenesis of experimental HDM-induced asthma. Thus, consistent with the context-dependent effects of rapamycin on inflammation, the timing of mTOR inhibition may be an important determinant of efficacy and toxicity in HDM-induced asthma.Keywords
This publication has 44 references indexed in Scilit:
- Apolipoprotein E Negatively Regulates House Dust Mite–induced Asthma via a Low-Density Lipoprotein Receptor–mediated PathwayAmerican Journal of Respiratory and Critical Care Medicine, 2010
- mTOR Signaling in LymphangioleiomyomatosisLymphatic Research and Biology, 2010
- Rapamycin Prevents Transforming Growth Factor-α–Induced Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Inactivation of Mammalian Target of Rapamycin Increases STAT1 Nuclear Content and Transcriptional Activity in α4- and Protein Phosphatase 2A-dependent FashionJournal of Biological Chemistry, 2009
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Toll/IL-1 Signaling Is Critical for House Dust Mite–specific Th1 and Th2 ResponsesAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Immunoregulatory functions of mTOR inhibitionNature Reviews Immunology, 2009
- House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cellsNature Medicine, 2009
- Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthmaJournal of Experimental Medicine, 2008
- Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or LymphangioleiomyomatosisNew England Journal of Medicine, 2008